These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24766)

  • 41. [Neurobiology of parkinsonism. I. Neural substrates an neurochemistry of the basal ganglia].
    Ponzoni S; Garcia-Cairasco N
    Arq Neuropsiquiatr; 1995 Sep; 53(3-B):706-10. PubMed ID: 8585835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distribution and release of GABA in the basal ganglia.
    Korf J; van der Heyden JA; Venema K; Postema F
    Adv Biochem Psychopharmacol; 1981; 30():105-17. PubMed ID: 7331934
    [No Abstract]   [Full Text] [Related]  

  • 43. [Senile Parkinsonism: its motor and psychological defects].
    Birkmayer W
    Aktuelle Gerontol; 1982 Sep; 12(5):166-7. PubMed ID: 6128932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Metabolism of acetylcholine and gamma-aminobutyric acid in the basal ganglia and limbic cortex of rats at different stages in the development of alcohol dependence].
    Maslova IV; Shevchenko NV; Balakleevskiĭ AI
    Vopr Med Khim; 1986; 32(1):110-6. PubMed ID: 3953003
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The neurophysiologic basis of abnormal movements in basal ganglia disorders.
    DeLong MR
    Neurobehav Toxicol Teratol; 1983; 5(6):611-6. PubMed ID: 6422317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Current aspects of extrapyramidal disorders].
    Ghika J
    Rev Med Suisse Romande; 1992 Jul; 112(7):605-9. PubMed ID: 1353898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Putative peptide neurotransmitters in human neuropathology: a review of topography and clinical implications.
    Constantinidis J; Bouras C; Richard J
    Clin Neuropathol; 1983; 2(2):47-54. PubMed ID: 6189657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurotransmitters in Huntington's Chorea--a clinician's view.
    Bruyn GW
    Prog Brain Res; 1982; 55():445-64. PubMed ID: 6131480
    [No Abstract]   [Full Text] [Related]  

  • 49. Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease.
    Ochi M; Shiozaki S; Kase H
    Neuroscience; 2004; 127(1):223-31. PubMed ID: 15219684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Neurotransmitters, drugs and neuropsychiatric diseases (author's transl)].
    Relja M; Lackvoić Z
    Lijec Vjesn; 1979 Oct; 101(10):609-16. PubMed ID: 44538
    [No Abstract]   [Full Text] [Related]  

  • 51. Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and Raphe nuclei.
    Molina-Holgado E; Dewar KM; Grondin L; van Gelder NM; Reader TA
    J Neurosci Res; 1993 Jul; 35(4):409-18. PubMed ID: 8360949
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [GABA and diseases of the extrapyramidal system].
    Carrieri P
    Acta Neurol (Napoli); 1977; 32(5):697-704. PubMed ID: 22223
    [No Abstract]   [Full Text] [Related]  

  • 53. Insight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinson's Disease and Huntington's Disease: A Review.
    Jamwal S; Kumar P
    Curr Neuropharmacol; 2019; 17(2):165-175. PubMed ID: 29512464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Interactions of neurotransmitters].
    Tanaka R
    Nihon Rinsho; 1978; 36(1):29-32. PubMed ID: 24762
    [No Abstract]   [Full Text] [Related]  

  • 55. Opioid hypofunction in Parkinson's disease.
    Sandyk R; Gillman MA
    Med Hypotheses; 1985 Feb; 16(2):179-82. PubMed ID: 2581117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemical neuroanatomy of the basal ganglia--normal and in Parkinson's disease.
    Hornykiewicz O
    J Chem Neuroanat; 2001 Jul; 22(1-2):3-12. PubMed ID: 11470551
    [No Abstract]   [Full Text] [Related]  

  • 57. Neurotransmitters and CNS disease. Dementia.
    Rossor MN
    Lancet; 1982 Nov; 2(8309):1200-4. PubMed ID: 6128503
    [No Abstract]   [Full Text] [Related]  

  • 58. Basal ganglia disease.
    Marsden CD
    Lancet; 1982 Nov; 2(8308):1141-7. PubMed ID: 6128460
    [No Abstract]   [Full Text] [Related]  

  • 59. Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease.
    Klockgether T; Turski L
    Trends Neurosci; 1989 Aug; 12(8):285-6. PubMed ID: 2475945
    [No Abstract]   [Full Text] [Related]  

  • 60. The biochemistry of the basal ganglia and Parkinson's disease.
    Curzon G
    Postgrad Med J; 1977 Dec; 53(626):719-25. PubMed ID: 24209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.